Find clinical trials for COVID-19 in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
COVID-19 trials near Atlanta, GA, USA:
vaccine (SARS-CoV-2 rS) adjuvanted with Matrix-M™ in previously mRNA COVID-19 vaccinated adult participants ≥18 years of age and ba-...
Phase 2, Phase 3
Lawrenceville, Georgia, United States and 29 other locations
for infectious pneumonia acquired in the community (CAP), including COVID-19.Secondary objectives:- To determine the effect of repa...
Phase 3
Atlanta, Georgia, United States and 108 other locations
This study looks at the safety and effectiveness of AZD7442 in treating COVID-19 in people who have been hospitalized with the infe...
Phase 3
Atlanta, Georgia, United States and 123 other locations
A Pilot Study of the Use of Oscillation and Lung Expansion (OLE) Therapy in Patients Hospitalized with COVID-19...
Atlanta, Georgia, United States and 1 other location
stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID...
Lilburn, Georgia, United States and 47 other locations
A study to investigate the prevention of COVID-19 with VYD222 in adults with immune compromise and in participants aged 12 years or...
Phase 3
Atlanta, Georgia, United States and 17 other locations
Performance of the LumiraDx SARS-CoV-2 Ag assay will be assessed by comparison to a reference method.
Atlanta, Georgia, United States and 6 other locations
a completed primary series and bivalent booster of mRNA based COVID-19 vaccine and have =<2500 U/mL SARS-CoV-2 S antibody concentra...
Phase 2
Atlanta, Georgia, United States and 5 other locations
The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a singl-...
Phase 2
Stockbridge, Georgia, United States and 29 other locations
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...
Phase 3
Atlanta, Georgia, United States and 217 other locations
Clinical trials
Research sites
Resources
Legal